Why Oncology Drugs Are Projected to Generate the Largest Pharma Revenues
Palm Beach, FL –November 19, 2019 – A lot of cancer research is dealing with shrinking brain tumors and opening the door for targeted cancer therapies to work without damaging the surrounding tissue. The success rate for cancer therapies has been limited due to a combination of factors, such as the tumor’s ability to hide […]
CNS Pharmaceuticals Acquired Worldwide Rights for Brain Cancer Drug from Houston Pharmaceuticals
Houston, TX – November 19, 2019 – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“Company”), a biotechnology company specializing in the development of novel treatments for brain tumors, completed an agreement with Houston Pharmaceuticals, Inc. (“HPI”) to obtain the rights to a worldwide, exclusive royalty-bearing, license for the chemical compound commonly known as Berubicin. CNS’ licensing […]
The 6 Top Gold Stories To Watch In 2020
FN Media Group Presents Oilprice.com Market Commentary London – November 19, 2019 – Some believe that it’s official. The trade war is leading us into a recession. Even Trump seems to think so. And for investors, that means one thing and one thing only. It’s time to hedge. Mentioned in today’s commentary includes: Newmont […]
Cancer Drugs Poised to Improve as New Developments Help Previous Therapies Target Better
FN Media Group Presents USA News Group Market Commentary Los Angeles, CA – November 18, 2019 – – USA News Group – A stunning revelation came back in April, when an Oxford published study pointed to only 3% of the cancer drugs tested between 2000 and 2015 were approved to treat patients, whereas another […]
Is This The Most Exciting Gold Find Of The Decade
FN Media Group Presents Oilprice.com Market Commentary London – November 18, 2019 – Gold major Barrick just tripled its profits. Newmont Goldcorp, also reported a big jump in profits over the last couple of months. But what most people don’t know is that most of the money is made in the discovery of new […]
Tapinator Reports Third Quarter 2019 Financial Results
— Revenue year-to-date grew 29% year-over-year to $3.0mm — Bookings year-to-date decreased 5% year-over-year to $2.5mm — Adjusted bookings year-to-date grew 16% year-over-year to $2.5mm — Adjusted Category Leading Apps bookings year-to-date grew 108% year-over-year to $1.7mm — Net loss year-to-date decreased 28% year-over-year to $1.5mm — Adjusted EBITDA year-to-date increased 50% year-over-year to $213k […]
This is Why CBD Companies are Just Beginning to Expand to International Markets
Palm Beach, FL – November 14, 2019 — By 2026, the global cannabis market is expected to hit $57 billion, says Adroit Market Research. In addition, according to BDS Analytics, as legalization spreads, the global market is expected to reach $40.6 billion by 2024. Granted, estimates vary, but it’s very clear the cannabis has plenty […]
Lithium Stocks Likely to Charge Higher on Chile’s Atacama Disruption
Palm Beach, FL – November 14, 2019 — In recent months, lithium prices slipped on oversupply issues, with producers cutting back on supply. However, those cuts are anticipated to eventually give way to a supply crunch. It’s why companies like Albemarle are still bullish on lithium. In addition, recent disruptions to lithium operations around Chile’s […]
Artificial Intelligence (AI) Global Market Projected To Exceed $200 Billion By 2026
Palm Beach, FL – November 14, 2019 – The Artificial Intelligence (AI) Market in North America has been rapidly growing over the past few years and is projected to continue to exhibit increasing growth through 2026. The North American market was valued at US$ 9.72 Billion in 2018 and the global market was valued at […]
Hoth Therapeutics Initiates Preclinical Study Including Topical Form of Aprepitant for Dermatological Treatment Relating to Side Effects of Cancer Medication
New York, NY – November 14, 2019 – Hoth Therapeutics, Inc. (NASDAQ: HOTH) (“HOTH” or the “Company”), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, today announced, in partnership with the George Washington University (GW), the initiation of a preclinical study of […]
